Cancer Susceptibility and Cancer Susceptibility Syndromes
January 29-February 1, 2014
The Westin San Diego
San Diego, CA
Alan D. D’Andrea, Dana-Farber Cancer Institute, Boston, MA
Phillip A. Dennis, Johns Hopkins University, Baltimore, MD
Pier Paolo Pandolfi, Beth Israel Deaconess Medical Center, Boston, MA
The study of rare human genetic cancer susceptibility syndromes has led to a broader view of cancer pathogenesis, diagnosis, and treatment in the general population. The systematic study of rare cancer-prone families has elucidated a complex network of cancer proteins and tumor suppressors, many of which function in DNA repair, cell cycle checkpoint control, and telomere maintenance. The primary focus of this AACR Special Conference was the cooperation of cancer susceptibility proteins in tumor initiation, progression, and metastasis; how mechanisms of control of mRNA/Protein Translation, when dysregulated, can lead to tumorigenesis; and how cancer susceptibility syndromes have elucidated new cell regulatory pathways.
Please visit the AACR Meetings & Workshops Calendar for a complete list of upcoming programs.
Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available